Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03993912
Title Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy (IFM2017_03)
Acronym IFM2017_03
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University Hospital, Lille
Indications
Therapies
Age Groups: senior
Covered Countries FRA


No variant requirements are available.